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Eosinophils are conspicuous components of the inflammatory response in a number 
of experimental and clinical states. They are present in peritoneal exudates following 
multiple intraperitoneal injections of foreign protein (1), and in the lymph nodes drain- 
ing sites of antigen administration (1-3). They may be found in  small numbers in 
guinea pig skin after the injection of antibody-antigen complexes (4), and in larger 
numbers when antigen alone is injected into a site that has previously developed a de- 
layed hypersensitivity reaction, the so-called "retest reaction"  (5). It is well known 
that eosinophils may be found in the nasopharynx and bronchi of patients with allergic 
conditions such as hay fever or asthma, and in the intestinal tract as a consequence of 
parasitic infestations. In these disease states, the only clear correlate with the presence 
of eosinophils is the allergic status of the patient. 
The existence of specific chemotactic factors for eosinophils has not been definitely 
established. In the horse, it is claimed that histamine will cause the accumulation of 
eosinophils (6), but this has not been confirmed in other species. In the various studies 
cited above, the role of antigen-antibody complexes appears crucial, but since these 
studies all involved intact animals, it is impossible to determine whether the complexes 
are themselves chemotactic or whether  they act in an indirect manner. This latter 
possibility is quite likely, in that it has been shown in vitro that immune complexes 
can activate the complement system to produce a  factor chemotactic for eosinophils 
(7). This complement-derived factor is the trimolecular complex C567 which had pre- 
viously been shown to be highly chemotactic for neutrophils (8, 9). Therefore, C567 is 
not selectively chemotactic for either type of granulocyte. Several other compounds 
with chemotactic activity for eosinophils, including enzymatic cleavage products of 
complement components and filtrates from bacterial cultures, all show a greater chemo- 
tactic activity with respect to neutrophils (7). 
In an elegant series of in vivo experiments, Basten, Boyer, and Beeson (10, 11) have 
recently found an association between the ability of rats to respond to Trichinella in- 
fection with a  peripheral eosinophilia and the presence of recirculating lymphocytes. 
They found that this ability could be transferred adoptively by intact cells in diffusion 
chambers, suggesting the role of a diffusible material. Although the nature of this fac- 
* Supported,  in part, by National Institutes of Health Grants AI-09114 and AI-07291, 
and by funds from a Dr. Henry C. and Bertha H. Buswell Research Fellowship. 
133 134  EOSINOPHIL  CHEI~,fOTACTIC  FACTOR 
tor was not determined, it was felt to be consistent with a specific kind of immuno- 
globulin such as homocytotropic antibody. 
It is known that when lymphocytes from experimental animals with delayed 
hypersensitivity are cultured in the presence of specific antigen, a large number 
of soluble factors  is released into the medium, including migratory-inhibition 
factor  (MIF)  1 (12,  13),  and factors chemotactic for macrophages and neutro- 
phils (14, 15). Moreover, Arnason and Waksman (5) have shown a relationship 
between delayed  hypersensitivity and  eosinophil accumulation in the  retest 
reaction. These observations, taken in conjunction with those of Basten et al. 
(10,  ll) and the studies relating immune complexes to eosinophil responses, all 
suggested the possibility that a substance chemotactic for eosinophils might be 
generated  by  the  three-way  interaction of  a  factor  derived  from  activated 
lymphocytes,  antibody, and antigen. The purpose  of  the  present paper is to 
describe such a factor and to define its in vitro and in vivo chemotactic activity 
for eosinophils. 
Materials  and Methods 
Eoslnophils.--Pefitoneal  exudates rich in eosinophils  were prepared according to the method 
of Litt (16). Hartley strain guinea pigs (40(0500 g) received a total of 12 intraperitoneal in- 
jections of keyhole limpet hemocyanin (KLH) (Calbiochem, Los Angeles, Calif.) in doses of 
10 mg per injection. With the exception of the first, each injection was preceded by the in- 
tramuscular  administration of 5 mg of diphenhydramine hydrochloride (Benadryl)  (Parka, 
Davis  & Co., Detroit, Mich.) with an interval of approximately 45 min between injections. 
Exudates  were collected in saline 36 hr after  the  last  injection of KLH with heparinized 
syringes, washed once, and  suspended in Medium  199  (Microbiological Associates, Inc., 
Bethesda, Md.). The suspensions so obtained were mixtures of neutrophils, eosinophils, and 
mononuclear cells. The ratio of eosinophils to neutrophils ranged from 20 to 35% in these 
experiments. 
Lymphocyte Factor.--Lymphocyte  culture fluids were kindly provided by Dr. John David, 
Harvard Medical School, Boston, Mass. These fluids war  obtained  by culturing hympho- 
cytes from guinea pigs sensitized to  the  antigen  o-chlorobenzoyl-bovine gamma globulin 
(OCB-BGG). Animals which served as cell donors all developed typical strong delayed-hyper- 
sensitivity reactions when skin tested with the antigen. The various lymph node cell suspen- 
sions used were divided into two parts, one being cultured in the presence of antigen (stimu- 
lated culture), and the other  in its absence (unstimulated culture).  In the  latter culture, 
antigen was routinely added at the end of the incubation  period. The production of MIF 
in stimulated cultures is a measure of the extent of in vitro  activation  of lymphocytes by 
antigen, and only those simulated cultures rich in MIF activity and their unstimulated controls 
were chosen for the present study. Details of the methodology involved have been previously 
described (13). A total of four different preparations  of culture  fluids, with  the  accompany- 
ing controls, were used in these experiments. 
Immune  Complexes.--Guinea pig and rabbit antisera were used. Each antiserum was ob- 
tained not less than 3 wk after the intradermal injection of the antigen in complete Freund's 
1 Abbreviations used in  this paper: BGG,  bovine gamma globulin; DNP-GPA,  dinitro- 
phenyl-guinea pig  albumin;  EA,  egg  albumin;  KLH,  keyhole limpet hemocyanin;  MIF, 
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adjuvant. The antigens used included bovine gamma globulin (BGG), egg albumin (EA), di- 
nitrophenyl-guinea pig albumin (DNP-GPA), and KLH. Immune complexes were prepared 
by reacting antibody with antigen at equivalence ratios in the presence of 5 X  10  .4 M  ethylene- 
diaminetetraacetate (EDTA). They were washed in 0.01 M phosphate-buffered saline at pH 
7.4. As an example of the nomenclature to be used in this paper, immune complexes of bovine 
gamma globulin and  rabbit anti-bovine gamma globulin formed at equivalence will be re- 
ferred to as RabaBGG-BGG. When a weight is given for the immune complex, it will refer to 
micrograms of antibody protein contained in that complex. 
Generation of Chemotactic A ctivity.--Washed, complement-free  immune  complexes  were incu- 
bated with 150 #1 of the various culture fluids in Medium 199 for 1/2 hr at 37 °C. The amount of 
complexes ranged from 180 to 300 #g. In most of the experiments to be described, the mixture 
of culture fluid and immune complexes was tested for chemotactic activity. However, in some 
cases the complexes were removed by centrifugation (2200 rpm, 20 min) after the period of 
incubation, and the supernates alone were tested. Removal or retention of the complexes after 
the period of incubation did not influence the degree of chemotactic activity generated. 
In  Vitro Assay System.--The  method used was the micropore filter assay which has been 
described in detail (8). In these assays of chemotactic activity, two compartments of a cham- 
ber were separated by a micropore filter of 5 #  pore size. The cell suspension, at a concen- 
tration of 2 X  l0  s granulocytes/ml, was made up in Medium 199 with  10% heat-inactivated 
guinea pig serum. The cell suspension was placed in the upper compartment (1 ml total vol- 
ume), while the lower compartment received the test material (1 ml total volume). Chemo- 
tactic activity was assessed by counting, in five randomly selected high-power fields, the num- 
ber of cells that had migrated completely through the filter and were on the opposite (lower) 
side of the filter,  after 4  hr of incubation at 37°C.  To  differentiate between granulocytes, 
filters were fixed  in  Hollande's fluid and processed according  to  Litt's modification of the 
Dominici stain (17). In each experiment the stimulated and unstimulated culture fluids were 
tested with and without treatment with immune complexes.  All the counts reported are net 
values and represent the difference between counts obtained from chambers containing stimu- 
lated cultures and those from chanbers containing unstimulated cultures. This corrects for 
the various background activities inherent in  the  assay.  Each experiment included cham- 
bers with immune complexes alone in the presence of Medium 199, Medium 199 alone, and in 
some cases antibody or antigen alone.  In addition, a chamber in each experiment contained a 
bacterial filtrate  (from  Escherlchia  coli) with known chemotactic activity for granulocytes 
(7). This was a positive control, in order to assess the reactivity of the indicator cells. 
In  Vivo Observatlons.--The  fluids from three active lymphocyte preparations were pooled 
for this experiment. The lymphocyte culture fluids were incubated with the various immune 
complexes for 90 rain at 37°C and the complexes were then removed by centrifugation at 2200 
rpm for 20 min. As controls, the complexes alone were incubated in Medium 199 and then re- 
moved in a similar manner. The incubation mixtures contained 210 #1 of culture fluids and 375 
#g of complexes. The various supernates were injected intradermally into guinea pig skin ac- 
cording to the following protocol. (a) unstimulated fluid,  (b) nnstimulated fluid q- GPaBGG- 
BGG,  (c)  unstimulated fluid  q-  GPaEA-EA,  (d)  stimulated fluid,  (e)  stimulated fluid  q- 
GPa.BGG-BGG,  (f) stimulated fluid -I- GPaEA-EA, (g) GPaBGG-BGG, and (h) GPaEA-EA. 
Reaction sites were excised  at  18 hr, fixed in Hollande's fluid,  and stained according to the 
IAtt procedure (17). Paraffin-embedded 5 #  sections were used. As will be described, the pat- 
terns of inflammation within the  variou  subgroups were sufficiently uniform so that total 
eosinophil counts over a fixed area gave a good quantitative description of the events at the 
various sites. A total of six sections from each reaction site were studied. A 1 cm segment from 
the central portion of each section was examined high-power field by high-power field, and the 
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RESULTS 
Background Activities.--As already indicated,  all of the in vitro assay results 
are  reported  as  net  values,  i.e.  counts  obtained  from  a  preparation  which 
includes stimulated lymphocyte culture fluid minus counts from a similar prepa- 
ration, but  one with unstimulated culture fluid.  Although  this procedure cor- 
rects for "background" activity, it is instructive to enumerate the actual con- 
tribution of the various substances to background. The data are shown in Table 
I.  Each  value  is  an  average of  from 8  to  12  determinations.  It is  seen that 
Medium  199  alone results  in  extremely low  counts,  with  an  average of  two 
eosinophils  (per five high-power fields).  The immune complexes alone,  in  the 
absence of lymphocyte culture fluid, similarly give low values. The same holds 
true for antibody alone and  antigen  alone,  which  are not shown in the  table. 
TABLE  I 
Chemotactic Activities Contributing to Background in the In Vitro Assay System 
Substance  Eosinophil count  4- SE 
Unstimulated fluid* (150 ~l) 
Immune complexes:~ (180-300/~g) 
Unstimulated fluid +  immune complexes 
Medium 199 
Bacterial factor§ 
124-5 
34-1 
94-1 
24-2 
124-2 
* Obtained from lymphocytes incubated in the absence of antigen. See text for details. 
2~ GPaBGG-BGG complexes  prepared at equivalence. 
§ Bacterial factor is included for comparison. 
The unstimulated  culture fluid,  in the  absence of immune complexes, gives a 
count of 12,  which is higher than the blank (Medium 199),  but this is not in- 
creased by the addition  of inlmune complexes. Shown also in the table is the 
eosinophil response to bacterial factor, which is of the same magnitude as that 
of  the  unstimulated  culture  fluid.  This  is  approximately 20-fold  lower  than 
results obtained with circulating human blood eosinophils (7)  and suggests that 
the protein-induced peritoneal eosinophils of the guinea pig behave sluggishly 
in  the  chemotactic  assay system.  This  observation underscores  the  high  po- 
tency of the eosinophil chemotactic factor to be described. 
Interaction of Lymphocyte Culture Fluids and Immune Complexes.--A typical 
experiment is shown in Table II. The stimulated culture fluids,  as previously 
indicated, were prepared from lymphocytes which had been sensitized to OCB- 
BGG.  As most  of the  systems involving lymphocyte activation  and/or  pro- 
liferation  appear to demonstrate  carrier specificity similar to that  of delayed 
hypersensitivity, antibody against BGG was utilized to form "specific" immune 
complexes. In this  experiment,  only the  combination  of stimulated  fluid  and 
immune complexes led to eosinophil chemotactic activity significantly greater STANLEY COHEN  AND  PETER A. WARD 
TABLE  II 
Result of a Typical Experiment Demonstrating the Generation oJ Eosinophil 
Chemotactic Activity 
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Material  tested*  Eosinophll  count:~  Eosinophil  response§ 
Unstimulated fluid  1 
Stimulated fluid  8 
Unstimulated fluid +  immune complexes  10 
Stimulated fluid +  immune complexes  105 
Medium 199  0 
Immune complexes  5 
Bacterial factor  15 
7 
95 
* Dosage and preparation  are described in the text. Unstimulated fluid is obtained from 
lymphocyte cultures incubated without antigen.  Stimulated fluid is obtained from cultures 
incubated with antigen. The immune complexes are GPaBGG-BGG. 
Number of eosinophils in five high-power fields  on the undersurface  of the micropore 
membrane. 
§ Difference in counts between the preparation  containing stimulated fluid and  the un- 
stimulated controls. 
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FIG.  1.  Eosinophil chemotactic response  to culture  fluids from four  antigen-stimulated 
lymphocyte preparations,  with  and  without  incubation  of the fluid with  specific  immune 
complexes (GPaBGG-BGG). The eosinophil response is measured as the difference  in counts 
between a chamber containing fluid from stimulated cultures and  a corresponding chamber 
containing fluid from unstimulated cultures. 
than  the  various  controls.  This  activity  is  approximately  six  times  that  of 
bacterial factor, a  substance previously shown to be chemotactic for eosinophils 
(7). 
Fig.  1  shows the eosinophil response,  as measured  by net eosinophil counts, 
of four different lymphocyte  culture preparations.  Each  value is the result  of 138  EOSINOPHIL  CIIEI~OTACTIC FACTOR 
four to five determinations. 150 ul of the various culture fluids was utilized for 
each determination. The immune complexes ranged from 180 to 300 ug (anti- 
body protein). No significant variation in response was  observed within this 
dose range, and the results are therefore grouped. 
In the absence of specific immune complexes, the culture fluid from antigen- 
stimulated  lymphocytes shows  slight  activity;  the  eosinophil  responses  are 
12, 1, 20, and 7. In the presence of immune complexes, the activity is marked, 
the eosinophil responses being 91,  80,  95,  and 125. It should be stressed that 
the complexes were prepared in the presence of EDTA and were well washed to 
exclude complement activity. Indeed, complexes alone, prepared in this manner, 
showed no significant chemotactic activity. In  these experiments, the whole 
mixture of lymphocyte culture fluid and complexes was added to the chambers 
and tested. In one experiment, following incubation of the two materials, the 
complexes were removed by centrifugation and only the supernatant was used. 
This supernate alone was  active, with  an  eosinophil response of 180.  In two 
experiments the antiserum was heat-inactivated at 56°C for 45 min, followed 
by the  addition  of antigen at equivalence in the presence of the lymphocyte 
culture fluid. This procedure also generated chemotactic activity and yielded an 
eosinophil response of  140.  Thus  the  interaction of stimulated  culture fluid, 
antibody,  and  antigen generated specific eosin0phil  chemotactic activity re- 
gardless  of the  sequence of addition  of the  reactants,  and  this  activity was 
found in the soluble phase. In this system we found it important to have anti- 
body and antigen at equivalence, since complexes prepared at ten times antigen 
excess were ineffective in generating chemotactic activity. 
Specificity of Chemotactic Factor.--The results reported thus far were obtained 
with immune complexes involving the same antigenic determinants as those to 
which the lymphocytes had been sensitized. To explore the specificity of the 
system, three other guinea pig antibodies were obtained. In addition, a rabbit 
antibody against the specific antigen (BGG), and a  rabbit antibody directed 
against an unrelated antigen were used. The results are shown in Table III, 
which lists  the average results for all experiments involving specific immune 
complexes made with guinea pig antibody as well.  The complexes containing 
antigens  unrelated to the  one used  in  the  original lymphocyte culture were 
ineffective in generating eosinophil chemotactic activity in the stimulated cul- 
ture  fluid.  Surprisingly,  related  but  heterologous  complexes  prepared  with 
rabbit antiserum (RabaBGG-BGG) were likewise ineffective. 
Chemotaxis of Neutrophils.--Since the peritoneal exudates contained mixtures 
of eosinophils and neutrophils, it was possible to compare the behavior of these 
two cell types under identical conditions in the in vitro assay system. In the 
present study, stimulated culture fluid alone was not effective in causing chemo- 
taxis of neutrophils. This is discordant with previous results (14,  15) but in all 
likelihood can be explained by the relatively small number of neutrophils used STANLEY COHEN AND PETER A.  WARD  139 
in the cell suspensions employed in these experiments,  and by the suboptimal 
methods (multiple intraperitoneal injections of protein) used for the preparation 
of these cells. In the previous experiments, neutrophils were obtained from the 
peritoneal cavity within 3-4 hr after the intraperitoneal  injection of glycogen. 
This  explanation  for the  relative  unresponsiveness  of the  neutrophils  is  sub- 
stantiated  by the observed effect of bacterial factor on these cells; this factor 
gave a mean neutrophil response of 70, which is markedly lower than the pre- 
viously reported values (18). In spite of this,  when specific immune complexes 
were added to the stimulated  culture fluid,  significant neutrophil  chemotactic 
activity was generated. A mean neutrophil response of 39 was obtained. 
Dose-Response Relationships.--Most  of  the  experiments  were  performed 
TABLE III 
Eosinophil  Chemotaztic Response to  Culture Fluids from  Antigen-Stlmulated  Lymphocytes: 
Effect of Treatment with Various Immune Complexes 
Immune complex*  Eosinophil response -4- SE$ 
None  10  ±  3 
GPaBGG-BGG  94  ±  10 
GPaEA-EA  <0 
RabaEA-EA  3  ±  3 
GPaKLH-KLH  <0 
GPaDNP-DNP  13  ±  8 
RabaBGG-BGG  3  4-  4 
* Lymphocytes were stimulated  with OCB-BGG. Resultant culture fluids were incubated 
at 37°C for 30 rain with immune complexes made at antigen equivalence. See Materials  and 
Methods for doses and details. 
:~ The eosinophil response is the difference in counts  between  the chambers  containing 
stimulated  fluid and the corresponding unstimulated  control. A value  <  0 means that the 
control had more counts. 
using  150 ~1  of  the  various  lymphocyte culture  fluids  treated  with  immune 
complexes ranging in amount from 180 to 300 ~g.  In this range there was no 
significant  difference  in  the  amount  of chemotactic  activity  generated.  This 
probably represents a plateau range, since stimulated culture fluid treated with 
50 ~g of complexes gave an eosinophil response of 20. Using varying amounts of 
stimulated  culture  fluid  treated  with  immune  complexes  in  the  180-300 ~g 
range,  the  chemotactic  response  of  eosinophils  was  a  direct  function  of  the 
volume of fluid tested.  In Fig.  2,  the results  are shown  as  a  semilogarithmic 
plot  of  the  eosinophil  response  as  a  function  of  the  amount  of  stimulated 
lymphocyte culture fluid. The response is clearly dose-dependent. 
In  Vivo  Observations.--Samples  of  various  preparations  which  had  been 
studied in the in vitro assay system were injected intradermally into guinea pig 
skin as described under Materials and Methods. For this purpose, the immune 140  EOSINOPHIL  CHEMOTACTIC  FACTOR 
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FIG. 2.  Eosinophil response as a function of the volume (#l)  of lymphocyte culture fluid. 
The response is dose-dependent over the range of values studied. 
TABLE IV 
Eosinophll Response in Guinea Pig Skin to Lymphocyte Culture Fluids Incubated with Various 
Immune  Complexes* 
Culture fluid  Immune complex;t  Reaction size  Eosinophil  count 4- sg 
(ram) 
Unstimulated§  None  8  5  4-  1 
Unstimulated  GPaBGG-BGG  11  81  4-  9 
Unstimulated  GPaEA-EA  9  14  4-  5 
Stimulated H  None  15  18  4-  3 
Stimulated  GPaBGG-BGG  16  209  4-  14 
Stimulated  GPaEA-EA  14  28  ±  6 
None  GPaBGG-BGG  0  1  4-  0.5 
None  GPaEA-EA  2  5  4-  2 
* Fluids were incubated  with complexes at 37°C for 90  min.  The complexes were then 
removed by centrifugation, and the supernates injected intradermally in a volume of 0.2 ml. 
:~ Immune  complexes were formed  at  equivalence. Each  contained  375  #g of antibody 
protein. 
§ Lymphocytes cultured in the absence of antigen. 
I] Lymphocytes cultured in the presence of antigen. 
complexes  and  lymphocyte  culture  fluids were  incubated  at  37°C  for 90 min, 
and  the  complexes were  then  removed by  centrifugation.  This  was  necessary 
since complexes alone will produce skin reactions in guinea pigs (4). The experi- 
mental results are summarized in Table IV which lists the preparations injected, 
the size of the reactions produced,  and the eosinophil response  at each site.  In 
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fluids produced  a  mixed inflammatory reaction with  a  large mononuclear  cell 
component,  similar  to  a  delayed  hypersensitivity  reaction.  Most  of  the  in- 
flammatory cells were located either high in the dermis near the epidermis,  or 
deep and adjacent to the muscle layer. The intervening area showed fewer in- 
filtrating cells. The unstimulated fluids produced a similar, but milder reaction, 
while the supernates from the complexes which were incubated without lympho- 
Fro.  3.  Cutaneous response to the injection of stimulated lymphocyte culture fluid treated 
with  specific immune  complexes  (GPaBGG-BGG).  A  marked  perivascular  inflammatory 
reaction is seen near the muscle layer. The majority of the infiltrating cells in this field are 
~osinophiles. Two  eosinophils (e)  and  one neutrophil  (n)  are  indicated  by arrows. X  560 
(modified Dominici). 
cyte fluid produced no skin reactions at all. The addition of either the GPaBGG- 
BGG or GPaEA-EA complexes to either of the culture fluids had no effect on 
the intensity of the skin response as measured grossly, or in terms of the num- 
bers of neutrophils and mononuclear cells present. There were, however, marked 
differences in the eosinophil response at the various sites. In agreement with the 
in vitro observations,  the  stimulated  fluid  alone  showed  slight  activity,  and 
this activity was markedly enhanced by treatment  with specific immune com- 
plexes. Un]ike the in vitro situation,  however,  the unstimulated  cultures  gen- 
erated  significant  activity  on incubation  with  specific  complexes,  suggesting 142  EOSINOPHIL  CHEMOTACTIC  FACTOR 
that there was sufficient activation of the lymphocytes in vivo, before culture 
to generate some of the factor involved in this response when placed in culture. 
This event was not detected in the chamber assay technique,  in vitro. 
Figs. 3 and 4 demonstrate the eosinophil response to stimulated culture fluids 
treated  with  specific  immune  complexes.  The  eosinophil  response  was  most 
marked  at the  sites at which  the  inflammatory response was most apparent, 
namely near the epidermis and near the muscle.  In any given field,  however, 
FIG.  4.  Eosinophils  (e)  in  the  upper  dermis.  Same  preparation  as  that  seen  in  Fig.  3. 
)<  990  (modified Dominici). 
there was no correlation between the number of eosinophils and the number of 
other cell types. 
DISCUSSION 
The  results  presented  demonstrate  the  existence  of  a  potent  chemotactic 
factor for eosinophils. This material is unique when compared with previously 
described factors chemotactic for other inflammatory cells,  since its generation 
is dependent not only upon the interaction of antibody with antigen,  but also 
with a substance elaborated by lymphocytes previously sensitized to the same 
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the previously defined substances such as migration-inhibitory factor, macro- 
phage chemotactic factor, or blastogenic factor, or it could represent an unusual 
and previously undetected immunoglobulin. In either case, the factor demon- 
strates immunologic specificity in that complexes prepared with unrelated anti- 
gens are ineffective  in bringing about generation of the chemotactic factor. There 
may be some analogy with the situation for MIF,  where Bennett and Bloom 
(20), Svejcar et al. (21), and Amos and Lachmann (22) have found evidence for 
the requirement of specific antigen in the expression of MIF activity. The last 
authors, for example, used antigen in insoluble form to stimulate lymphocyte 
cultures.  The  resulting  antigen-free supernatants  required  the  readdition  of 
(soluble) antigen for full MIF activity. 
The apparent species specificity seen here (RabaBGG-BGG is ineffective) is 
puzzling; it is  conceivable that  a  specific immunoglobulin type is required to 
participate in the formation of the immune complexes, and that this immuno- 
globulin was present in the guinea pig but absent in the rabbit preparations 
used. Resolution of this point will await the examination of a large number of 
well-characterized antisera.  If species specificity is  confirmed, a  possible  ex- 
planation is that the recognition site on the lymphocyte-derived factor is di- 
rected toward some determinant formed by the union of antibody and antigen. 
Since this specificity had been generated in vivo during the course of active 
sensitization, the antibody involved was the guinea pig's own, and thus guinea 
pig  antibody would be required in the in vitro system. There may be some 
analogies  here  with  delayed hypersensitivity,  where  antigen-antibody  com- 
plexes are potent sensitizing agents (23), and where antigen-antibody complexes 
may readily elicit the reaction (24). Unfortunately, little work has been done 
to explore the specificity relationships in these situations. 
For ease of experimental manipulations, in most experiments the complexes 
and the lymphocyte factor were not separated after incubation, before in vitro 
testing. However, in a small number of experiments, it has been established that 
(a) the continued presence of the complex following incubation is not necessary 
for chemotactic activity,  and  (b)  preformed complexes are  not  necessary to 
generate the eosinophil chemotactic factor, i.e., antibody and antigen can react 
in  the presence of the lymphocyte culture fluid. Because washed complexes, 
formed and reacted with the culture fluid in the presence of EDTA were used, a 
role for the products of sequential complement activation can be excluded in this 
system. It appears essential, however, that the antibody and antigen be present 
in  equivalence ratios;  in  experiments not  reported here,  immune  complexes 
made  in  antigen  excess  have  been  ineffective in  generating  the  eosinophil 
chemotactic factor. 
Under the experimental conditions described, neutrophils also react chemo- 
tactically. There is  no evidence that  this is due to the existence of a  second 
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The eosinophil activity is clearly primary in that  the maximal eosinophil re- 
sponse was two and one half times that of the neutrophil response, in spite of 
the fact that the indicator cell system contained from two to four times as many 
neutrophils  as  eosinophils.  Moreover, bacterial factor,  which  was  used  as  a 
positive  control,  was  approximately  six  times  more  effective  in  attracting 
neutrophils  than  eosinophils,  so  that  although  the  neutrophils  were weakly 
reactive as  compared to  glycogen-stimulated cells,  as  previously mentioned, 
the eosinophils enjoyed no preferential advantage in this regard. 
The  in  vivo activity observed suggests  the  biological effectiveness of the 
factor described,  and  provides an  explanation for the retest phenomenon as 
observed by Arnason and Waksman (5). In this situation, retest at the site of a 
previous delayed hypersensitivity reaction leads to the accumulation of eosino- 
phils at that site. Although the authors found no detectable circulating anti- 
body,  they  suggested  the  possibility  of local  antibody production  that  was 
undetectable by their method (neutralization of diphtheria toxin). Treatment 
of their animals with anti-lymphocyte serum abolished the retest reaction. Our 
results would suggest, in contrast with those of Arnason and Waksman, that a 
skin test at a virgin site in an animal making antibody as well as delayed hyper- 
sensitivity should contain eosinophils as well. Preliminary studies support this 
contention. Another prediction currently being tested is  that  elicitation of a 
delayed reaction with immune complexes, rather than antigen, should evoke an 
eosinophil response. 
The studies  reported here are relevant also to the  observations of Basten, 
Boyer, and Beeson  (10,  11)  who found that procedures which deplete or in- 
activate the pool of recirculating lymphocytes in rats  (such  as thymectomy, 
anti-lymphocyte serum administration,  or thoracic duct drainage)  all cause a 
diminution in the eosinophil response in trichinosis. Possibly as a consequence 
of parasitic infestation, the rats generate a  lymphocyte-derived, antigen- and 
antibody-dependent chemotactic factor in  vivo which  is  similar  to  that  de- 
scribed in the present study. 
The  results  presented  establish  one  mechanism  for  the  accumulation  of 
eosinophils. This mechanism is based upon the generation of chemotactic ac- 
tivity by  the  interaction  of  a  soluble  factor produced  by  antigen-activated 
lymphocytes with immune complexes. As indicated, the resulting chemotactic 
factor's effectiveness in vivo as well as in vitro suggests that it plays a  role in 
biological reactions in the intact animal.  Doubtless,  many other mechanisms 
may be operative in this  situation as well. Little is known about the ultimate 
function of eosinophils. However, as they are highly phagocytic for antigen (3) 
and for antigen-antibody complexes (1), their accumulation in lymphoid tissue 
and at sites of peripheral immunologic reactions suggests a possible regulatory 
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When cultured in the presence of specific antigen, lymphocytes from delayed- 
hypersensitive guinea pigs release a  number of biologically active substances 
into  the  culture  medium.  Such  active supernatants  can  react  with  immune 
complexes in vitro to generate  a  factor which  is chemotactic for eosinophils. 
The factor involved is unique,  since previously described chemotactic factors 
for other cell types require  for their generation  either  immune complexes or 
substances released into lymphocyte culture,  but not both. In the case of the 
eosinophil chemotactic factor, the interaction between the substance elaborated 
by the lymphocytes and the immune complexes appears to be specific in that 
the immune complexes must contain the same antigen as that used to activate 
the  lymphocyte cultures.  Although  this  factor was  generated  in  an  in  vitro 
system, it has been shown to possess in vivo as well as in vitro activity. It is 
therefore possible that this factor may be of biological significance in situations 
where eosinophils are participants in inflammatory or immunologic reactions. 
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